Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

3038

Actual shortage: 229 (8%)
Anticipated shortage: 14 (0%)
Avoided shortage: 9 (0%)
Resolved: 2786 (92%)

Discontinuation Reports

356

To be discontinued: 22 (6%)
Discontinued: 334 (94%)
Reversed: 0 (0%)

Late reports

142 (4%)

Overdue reports

31 (12%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-OXYCODONE CR 80.0MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-23 2023-08-12 196312
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-04 199527
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-07-27 2024-03-15 200177
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-13 2023-10-15 201719
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-11-06 202824
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-08-23 2023-09-01 202830
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-10-20 203804
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-09-07 2023-09-19 203855
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-09-28 2024-03-15 205480
APO-GLICLAZIDE MR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-02-16 206563
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-06 2024-01-12 206579
APO-OXYCODONE CR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-06 208382
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-27 2023-11-10 208400
APO-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-06 2024-03-15 209286
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-04-19 209298
APO-GUANFACINE XR 1MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2024-01-12 209339
APO-ALFUZOSIN 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-06 2023-12-15 209372
APO-FELODIPINE 5MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-17 2024-02-02 210689
APO-FELODIPINE 10MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-24 2024-02-09 211484
APO-METFORMIN ER 500MG TABLET (EXTENDED-RELEASE) Resolved 2023-12-01 2024-01-26 212362

Showing 2941 to 2960 of 3038

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-SUCRALFATE - TAB 1G 1G TABLET Discontinued 2018-09-10 2018-09-15 61033
APO-TADALAFIL 20MG TABLET Discontinued 2018-09-10 2019-02-13 61045
APO-TAMOX TAB 20MG 20MG TABLET Discontinued 2018-09-10 2019-09-12 61050
APO-ACETAMINOPHEN 325MG TABLET Discontinued 2018-10-11 2018-10-11 63845
APO-RISEDRONATE 35MG TABLET Discontinued 2018-10-19 2018-10-19 64965
ACETAMINOPHEN CAPLETS 325 MG 325MG TABLET Discontinued 2018-10-25 2018-10-25 65585
APO-LOSARTAN/HCTZ 12.5MG 100MG TABLET Discontinued 2018-11-19 2018-11-19 67146
APO DIMENHYDRINATE TAB 50MG 50MG TABLET Discontinued 2019-01-02 2019-01-02 70787
APO-IBUPROFEN 300MG TABLET Discontinued 2019-01-02 2019-01-02 70793
APO-IBUPROFEN 400MG TABLET Discontinued 2019-01-02 2019-01-02 70799
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-02-21 70802
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-07-13 70805
APO-ACETAMINOPHEN EXTRA STRENGTH 500MG TABLET Discontinued 2019-01-02 2019-08-08 70807
APO-RANITIDINE TABLET 150MG 150MG TABLET Discontinued 2019-01-02 2019-01-09 70810
APO-PRAVASTATIN 20MG TABLET Discontinued 2019-01-03 2019-01-03 71014
APO-ALENDRONATE 5MG TABLET Discontinued 2019-01-03 2019-12-21 71023
APO-ALENDRONATE 10MG TABLET To be discontinued 2019-01-03 2019-12-20 71026
APO-VALSARTAN/HCTZ 12.5MG 160MG TABLET Discontinued 2019-01-03 2019-01-03 71054
APO-ZOLMITRIPTAN 2.5MG TABLET Discontinued 2019-01-03 2019-01-03 71072
APO-LOSARTAN/HCTZ 12.5MG 50MG TABLET Discontinued 2019-01-03 2019-01-03 71101

Showing 281 to 300 of 356